Treatment of congestive heart failure by pretreated...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/14 (2006.01) A61K 41/00 (2006.01) A61P 9/04 (2006.01)

Patent

CA 2400801

A method of treating congestive heart failure (CHF) in a human patient comprises treating an aliquot of the patient's blood ex vivo with at least one stressor selected from the group consisting of a temperature above or below body temperature, an electromagnetic emission and an oxidative environment, followed by administering the aliquot of treated blood to the patient. The treatment can be used on its own or as an adjunctive therapy in combination with conventional CHF treatments.

L'invention concerne une méthode de traitement de l'insuffisance cardiaque congestive (ICC) chez un patient humain, qui consiste à traiter une aliquote de sang du patient <i>ex vivo</i> par exposition à un facteur stressant, tel qu'une température supérieure ou inférieure à la température du corps, une émission électromagnétique et un environnement oxydant, puis à administrer ladite aliquote de sang traité au patient. Ledit traitement peut être utilisé seul ou à titre complémentaire, conjointement avec des traitements classiques de la ICC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of congestive heart failure by pretreated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of congestive heart failure by pretreated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of congestive heart failure by pretreated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1787739

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.